Physician profile
Bryce Child
NPI 1326867508
$1,246.23
in general payments reported to CMS, 2019-2025
24 companies · $1,246 in 2025
The $1,246 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,146 · Education: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,146.23 |
| Education | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $160.44 | 2025 | Adstiladrin |
| Pfizer INC. | $130.04 | 2025 | |
| Abbvie INC. | $101.52 | 2025 | |
| Intuitive Surgical, INC. | $100.00 | 2025 | |
| Progenics Pharmaceuticals, INC. | $83.22 | 2025 | |
| Urogen Pharma, INC. | $75.24 | 2025 | |
| Blue Earth Diagnostics | $62.90 | 2025 | Posluma |
| Procept Biorobotics Corporation | $53.47 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $52.10 | 2025 | |
| Novartis Pharmaceuticals Corporation | $49.85 | 2025 | |
| Tolmar, INC. | $45.98 | 2025 | Eligard, Jatenzo |
| Immunitybio, INC. | $43.19 | 2025 | |
| Janssen Biotech, INC. | $37.03 | 2025 | Erleada |
| Cycle Pharmaceuticals INC | $30.75 | 2025 | Venxxiva |
| Teleflex LLC | $30.53 | 2025 | Barrigel |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $30.52 | 2025 | Xiaflex, Aveed |
| Sumitomo Pharma America, INC. | $29.89 | 2025 | Orgovyx |
| Laborie Medical Technologies Corp. | $21.38 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Coloplast Corp | $20.76 | 2025 | |
| Bioprotect Medical, INC. | $19.83 | 2025 | Bioprotect Balloon Implant System |
| Antares Pharma, INC. | $18.27 | 2025 | Xyosted |
| Astellas Pharma US INC | $17.77 | 2025 | Xtandi |
| Inspire Medical Systems, INC. | $17.48 | 2025 | Inspire |
| 180 Medical, INC. | $14.07 | 2025 | Gentlecath Glide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryce Child listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.